首页> 美国卫生研究院文献>other >The Strategic Defense of Physician Autonomy: State Public Health Agencies as Countervailing Powers
【2h】

The Strategic Defense of Physician Autonomy: State Public Health Agencies as Countervailing Powers

机译:医师自治的战略防御:国家公共卫生机构作为反补贴力量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Advances in genetic testing and the aggressive marketing of genetic tests by commercial diagnostic laboratories have driven both consumer demand and the need for unbiased information about how tests should guide healthcare delivery. This paper uses the countervailing powers framework to explore the role of state public health agencies as arbiters of quality and safety, specifically through their efforts to encourage physicians to follow evidence-based recommendations for screening for hereditary cancers. Social scientists have often viewed actions by the state to regulate cost, quality, or safety as a threat to physician autonomy. This paper draws on case studies from two US states—Michigan and Connecticut—to better understand the specific role of state public health agencies, and especially whether their activities to encourage adherence to evidence-based recommendations bolster or subvert the interests of other parties in the healthcare arena. We find that lacking authority to compel provider to follow evidence-based recommendations, they improvised ways to foster compliance voluntarily, for example, by emphasizing the role of the physician as gatekeeper, thus affirming the importance of physician autonomy and clinical judgment. Both states also used public health surveillance data to make rare diseases visible and illustrate gaps between recommendations and practice. Finally, they both showed that following evidence-based recommendations could align the professional and market interests of healthcare stakeholders. Both states employed similar strategies with similar effects, despite substantial differences in the regulatory climate and organizational capacity. Taken as a whole, their activities orchestrated a countervailing response that checked the profit-seeking motives of commercial laboratories. Our findings demonstrate that rather than eroding physician autonomy, state action to monitor healthcare quality and encourage adherence to evidence-based recommendations can actually reinforce physician authority.
机译:商业诊断实验室在基因检测和基因检测的积极销售方面的进步推动了消费者需求以及对有关检测应如何指导医疗保健提供公正信息的需求。本文使用反补贴框架来探讨州公共卫生机构作为质量和安全仲裁者的作用,特别是通过鼓励医生遵循循证医学筛查遗传性癌症的建议。社会科学家经常将国家为规范成本,质量或安全性而采取的行动视为对医师自主权的威胁。本文以美国密歇根州和康涅狄格州两个州的案例研究为基础,以更好地了解州公共卫生机构的具体作用,尤其是它们为鼓励遵守循证医学建议而开展的活动是否能促进或颠覆其他各方在该州的利益。医疗保健领域。我们发现,由于缺乏权力来迫使医疗服务提供者遵循循证医学的建议,他们提出了自愿促进依从性的方法,例如,通过强调医师作为看门人的作用,从而肯定了医师自主性和临床判断的重要性。两国还利用公共卫生监测数据使罕见病可见并说明建议与实践之间的差距。最后,他们都表明遵循循证建议可以使医疗保健利益相关者的专业和市场利益保持一致。尽管监管环境和组织能力存在很大差异,但这两个州都采用了类似的策略,且效果相似。从总体上看,他们的活动精心安排了反补贴的应对措施,从而遏制了商业实验室的牟利动机。我们的研究结果表明,采取行动监控医疗质量并鼓励遵守循证医学建议,实际上可以增强医师的权威,而不是削弱医师的自主权。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号